Qlaris Bio to Present at Glaucoma 360 New Horizons Forum
DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a biotechnology company targeting high unmet needs in debilitating ophthalmic diseases, announced today that Thurein Htoo, MS, MBA, the company’s co-founder and chief executive officer, will present during the 12th Annual Glaucoma 360 New Horizons Forum on Friday, Feb. 3, 2023, at 8:40 a.m. PT...
